Evans D G, Evans D J, Gorbach S L
Infect Immun. 1973 Nov;8(5):731-5. doi: 10.1128/iai.8.5.731-735.1973.
Twenty-five strains of enterotoxigenic (tox(+)) Escherichia coli isolated in India, Bangladesh, and the U.S.A. were shown to produce vascular permeability factor (PF) activity as well as diarrheagenic activity. Sixteen strains of non-enterotoxigenic E. coli were found to be PF negative. The PF response elicited by tox(+)E. coli isolated in the U.S.A. from cases of infantile diarrhea was qualitatively different and more difficult to demonstrate. However, this problem was surmounted by assaying 25-fold concentrates of the crude enterotoxin of these strains. PF activity of various strains of tox(+)E. coli was neutralized by anti-PF antiserum prepared against the enterotoxin of strain H-10407. This anti-PF antiserum also neutralized PF activity of Vibrio cholerae enterotoxin (choleragen). Antiserum containing antibody specific for purified choleragen neutralized E. coli PF activity. These and other results indicate that the PF activity of E. coli is a function of the diarrheagenic enterotoxin as is known to be the case with choleragen. We conclude that the PF assay can be employed for the identification of tox(+)E. coli and for the detection of antitoxic antibody.
在印度、孟加拉国和美国分离出的25株产肠毒素(tox(+))大肠杆菌被证明能产生血管通透因子(PF)活性以及致泻活性。发现16株非产肠毒素大肠杆菌PF呈阴性。在美国从婴儿腹泻病例中分离出的tox(+)大肠杆菌引发的PF反应在性质上有所不同,且更难证明。然而,通过检测这些菌株粗制肠毒素的25倍浓缩物克服了这个问题。各种tox(+)大肠杆菌菌株的PF活性被针对H-10407菌株肠毒素制备的抗PF抗血清中和。这种抗PF抗血清也中和了霍乱弧菌肠毒素(霍乱原)的PF活性。含有针对纯化霍乱原的特异性抗体的抗血清中和了大肠杆菌的PF活性。这些以及其他结果表明,大肠杆菌的PF活性是致泻性肠毒素的一种功能,霍乱原的情况也是如此。我们得出结论,PF检测可用于鉴定tox(+)大肠杆菌和检测抗毒素抗体。